We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo ADLM 2026 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Home Diagnostics Merges with Nipro Diabetes Systems

By LabMedica International staff writers
Posted on 16 Jun 2010
Home Diagnostics, Inc. (Fort Lauderdale, FL, USA) and Nipro Diabetes Systems, Inc. (Miramar, Florida, USA) announced that the two companies are merging to become Nipro Diagnostics, Inc.

Both companies are wholly owned by Nipro Corporation (Osaka, Japan), a multibillion-dollar company, and a world leader in providing medical products to the healthcare community.

Home Diagnostics manufactures and markets the TRUE brand of quality, high-performance blood glucose monitoring systems. These products are affordable, accurate, and reliable. The company supplies blood glucose monitoring systems for medical products distributors, national retail pharmacies, pharmacy wholesalers, and mail-order suppliers.

Nipro Diabetes Systems manufactures and markets the Amigo insulin pump that helps keep blood glucose in control for children and adults with types 1 and 2 diabetes. Built for safety, reliability, accuracy and durability, the insulin pump features computer like help screens for easy programming.

The merger of the two companies results in a comprehensive diabetes monitoring and insulin-management product portfolio, which few companies offer. This portfolio will help to ensure that patients and healthcare professionals have easy access to high-quality diabetes monitoring and management tools.

The name change to Nipro Diagnostics, Inc. is effective immediately for Home Diagnostics. The merger of the two companies is expected to be completed by the end of the year 2010.

Related Links:

Home Diagnostics, Inc.
Nipro Diabetes Systems, Inc.
Nipro Corporation




New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Online QC Software
Acusera 24•7
Automatic CLIA Analyzer
Shine i6000
Clinical Informatics Platform
CLARION™

Latest Industry News

Collaboration Advances Extracellular Vesicle-Based Tests for Neurodegenerative Diseases
16 Jun 2010  |   Industry

Tempus to Acquire Personalis in $1.5 Billion Precision Oncology Deal
16 Jun 2010  |   Industry

Bruker Expands NGS Capabilities for Sepsis and Bloodstream Infections
16 Jun 2010  |   Industry



PURITAN MEDICAL